Overdiagnosis in Lung Cancer Screening, Cost-Effectiveness of Computed Tomography Screening for Lung Cancer, and Decision Analysis of Need for Biopsy-proven Diagnosis before Stereotactic Ablative Radiotherapy for Lung Cancer
- PMID: 26331789
- DOI: 10.1164/rccm.201504-0804RR
Overdiagnosis in Lung Cancer Screening, Cost-Effectiveness of Computed Tomography Screening for Lung Cancer, and Decision Analysis of Need for Biopsy-proven Diagnosis before Stereotactic Ablative Radiotherapy for Lung Cancer
Comment on
-
Overdiagnosis in low-dose computed tomography screening for lung cancer.JAMA Intern Med. 2014 Feb 1;174(2):269-74. doi: 10.1001/jamainternmed.2013.12738. JAMA Intern Med. 2014. PMID: 24322569 Free PMC article. Clinical Trial.
-
When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis.Chest. 2014 Oct;146(4):1021-1028. doi: 10.1378/chest.13-2924. Chest. 2014. PMID: 24853550
-
Cost-effectiveness of CT screening in the National Lung Screening Trial.N Engl J Med. 2014 Nov 6;371(19):1793-802. doi: 10.1056/NEJMoa1312547. N Engl J Med. 2014. PMID: 25372087 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
